Table 1. Patient characteristics at baselinea
| n or Mean | % or SD | |
|---|---|---|
| a EPO, erythropoietin; BMI, body mass index; nPNA, nPCR, normalized protein catabolic rate. | ||
| b To convert from g/dl to g/L, multiply by 10. | ||
| c To convert from g/dl to mmol/L, multiply by 0.25; to mEq/L, multiply by 0.5. | ||
| d To convert from g/dl to mmol/L, multiply by 0.323. | ||
| Age (yr; n [%]) | ||
| <45 | 89 | 12.0 |
| 45 to 60 | 185 | 25.0 |
| 60 to 70 | 203 | 27.4 |
| >70 | 263 | 35.5 |
| Gender (n [%]) | ||
| male | 425 | 57.4 |
| female | 315 | 42.6 |
| Primary kidney disease (n [%]) | ||
| Diabetes | 111 | 15.0 |
| Glomerulonephritis | 76 | 10.3 |
| Renal vascular cause | 157 | 21.2 |
| All other | 396 | 53.5 |
| Davies’ comorbidity score (n [%]) | ||
| no | 296 | 40.0 |
| intermediate | 361 | 48.8 |
| high | 83 | 11.2 |
| SGA score (n [%]) | ||
| ≤4 | 108 | 14.6 |
| 5 | 138 | 18.7 |
| 6 | 282 | 38.1 |
| 7 | 212 | 28.7 |
| No. of patients treated with EPO (n [%]) | 669 | 90.4 |
| Albumin (g/dlb; mean [SD]) | 3.66 | 0.48 |
| Hemoglobin (g/dlb) | 10.7 | 1.4 |
| BMI (kg/m2) | 24.6 | 4.5 |
| nPCR (g/kg per d) | 1.00 | 0.23 |
| Calcium (mg/dl)c | 9.36 | 1.0 |
| Phosphorus (mg/dl)d | 5.85 | 1.76 |
| Systolic BP (mmHg, before/after session) | 154/142 | 21/21 |
| Diastolic BP (mmHg, before/after session) | 82/78 | 11/11 |